Skip to main content

Table 1 Anthropometric, clinical and laboratory data of the whole population

From: Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

Patients

HS at US

HS at US

HS at US

p

Group

score 1

score 2

score 3

 

n

52

128

20

 

Age Median years

45

48

49.5

0.27

(IQR)

(25-51)

(37.5-53.5)

(35-55)

 

BMI Median

37.7

43

49.2

0.005â–¡

(IQR)

(33.6-40)

(38-46.8)

(44-55)

 

Groups' difference

1 from 2

1 from 3

2 from 3

 

WC (f) Median cm

110

124

130

0.003â–¡

(IQR)

(104-118)

(118-131)

(124-138)

 

Groups' difference

1 from 2

1 from 3

2 from 3

 

WC (m) Median cm

116

127

138

0.01â–¡

(IQR)

(110-125)

(123-136)

(134-148)

 

Groups' difference

1 from 2

1 from 3

2 from 3

 

HOMA Median

2.3

3.1

4.08

0.0037â–¡

(IQR)

(1.18-3.05)

(1.97-4.58)

(3.37-5.89)

 

Groups' difference

1 from 2

2 from 3

3 from 1

 

Total Cholesterol

201

180

190

0.2

Median mg/dL

(49-222)

(156-210)

(165-205)

 

(IQR)

    

HDL Cholesterol (f)

54.1 ± 11.5

46.6.1 ± 20.2

38.75 ± 16.6

0.047•

m±SD mg/dL

1 from 2

2 from 1

  

Groups' difference

    

HDL Cholesterol (m)

39.37 ± 16.5

41.9 ± 13.2

45.6 ± 16.6

0.56

m±SD mg/dL

    

Ferritin (f)

46.2 ± 22.4

61.7 ± 41.1

74.5 ± 22.4

0.43

m±SD ng/mL

    

Ferritin (m)

197.9 ± 49.6

221 ± 121.7

164.8 ± 23.2

0.72

m±SD ng/mL

    

Triglycerides

129 ± 89

151 ± 79

204 ± 121

0.07

m±SD mg/dL

    

SAT cm (f)

2.6 (1.4-2.8)

2.9 (2.6-3.6)

3.5 (3.2-4.3)

0.015â–¡

Groups' difference

1 from 2

2 from 1

3 from 1

 

SAT cm (m)

1.9 (1.6-2.4)

2.3 (1.9-2.7)

3.5 (2.2-3.7)

0.035*

Groups' difference

1 from 2 and 3

2 from 1 and 3

3 from 1 and 2

 

VAT cm (f)

4.5 (4-6.1)

7.1 (6.1-8)

8.2 (8-8.7)

0.001â–¡

Groups' difference

1 from 2

2 from 1

3 from 1

 

VAT cm (m)

6.3 (5.6-6.7)

9.2 (7.8-11)

11.5 (9.2-15)

0.0001*

Groups' difference

1 from 2 and 3

2 from 1 and 3

3 from 1 and 2

 

SBP mm Hg

125 (120-140)

130 (120-140)

140 (130-160)

0.0002*

Groups' difference

1 from 2 and 3

2 from 1 and 3

3 from 1 and 2

 

DBP mm Hg

85 (80-90)

80 (80-90)

80 (80-95)

0.2

SLD mm

108 (95-118)

111 (100-121)

122 (110-140)

0.06

CRP mg/L

0.3 (0.2-07)

0.8 (0.6-1.5)

1.6 (0.7-2.5)

0.002*

Groups' difference

1 from 2 and 3

2 from 1 and 3

3 from 1 and 2

 

Fibrinogen mg/dL

290 (240-320)

300 (260-350)

290 (250-400)

0.56

γ-GT U/L

22 (15-36)

25 (19-45.5)

29.5 (27-41)

0.1

ALT U/L

26 (19-40)

30 (27-39)

34 (30-46)

0.17

T2D yes/not

12/40

34/94

7/13

0.33

IFG yes/not

15/37

37/91

9/11

0.42

Hypertension

16/36

47/81

12/8

0.004

yes/not

    

MS yes/not

20/32

70/58

13/7

0.002

IMT Median cm

0.08 (0.06-0.11)

0.11(0.09-0.13)

0.12 (0.10-0.13)

0.02#

Groups' difference

1 from 2

2 from 1

  
  1. HS, hepatic steatosis; BMI body mass index; WC waist circumference; HOMA homeostasis model assessment of insulin resistance; SAT subcutaneous adipose tissue at ultranonography (US), VAT visceral adipose tissue at US; BSP blood systolic pressure; DBP diastolic blood pressure; SLD spleen longitudinal diameter at US; CRP c reactive protein; γ-GT gamma glutamyl transferase; ALT alanine aminotransferase; T2D type 2 diabetes mellitus; IFG impaired fasting glucose; MS metabolic syndrome; IMT intima media thickness